Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01317329 · ClinicalTrials.gov registry record · NA

"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"

A NA study of Obesity and Hypertension, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT01317329 is a NA study of Obesity and Hypertension that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 90 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01317329, a NA study of Obesity and Hypertension, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the factors that are associated with improved cardiovascular function with the use of CPAP therapy on subjects diagnosed with moderate to severe obstructive sleep apnea.

Interventions

  • OTHER Clinically prescribed CPAP therapy

Study Locations (1)

Wisconsin

  • Wisconsin Sleep - Madison

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2011-03
Est. Completion 2014-12
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT01317329

The ClinicalTrials.gov registry entry for NCT01317329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Clinically prescribed CPAP therapy is the first listed.

NCT01317329 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01317329 about?

NCT01317329 is a clinical study titled ""Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"". The purpose of this study is to determine the factors that are associated with improved cardiovascular function with the use of CPAP therapy on subjects diagnosed with moderate to severe obstructive sleep apnea.

What is the current status of trial NCT01317329?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-03. Estimated completion is 2014-12.

What conditions does trial NCT01317329 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Sleep Apnea, Obstructive, Hypoxia, Sleep Disorders.

What interventions are being tested in trial NCT01317329?

The interventions under investigation include: Clinically prescribed CPAP therapy (OTHER).

Who is sponsoring clinical trial NCT01317329?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01317329 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.